114 related articles for article (PubMed ID: 15351849)
21. Priming for enhanced alveolar fibrin deposition after hemorrhagic shock: role of tumor necrosis factor.
Fan J; Kapus A; Li YH; Rizoli S; Marshall JC; Rotstein OD
Am J Respir Cell Mol Biol; 2000 Apr; 22(4):412-21. PubMed ID: 10745022
[TBL] [Abstract][Full Text] [Related]
22. Ethanol-induced up-regulation of the urokinase receptor in cultured human endothelial cells.
Tabengwa EM; Grenett HE; Benza RL; Abou-Agag LH; Tresnak JK; Wheeler CG; Booyse FM
Alcohol Clin Exp Res; 2001 Feb; 25(2):163-70. PubMed ID: 11236828
[TBL] [Abstract][Full Text] [Related]
23. The fibrinolytic system in neoplasia.
Bell WR
Semin Thromb Hemost; 1996; 22(6):459-78. PubMed ID: 9122711
[TBL] [Abstract][Full Text] [Related]
24. Salmeterol enhances pulmonary fibrinolysis in healthy volunteers.
Maris NA; de Vos AF; Bresser P; van der Zee JS; Jansen HM; Levi M; van der Poll T
Crit Care Med; 2007 Jan; 35(1):57-63. PubMed ID: 17080003
[TBL] [Abstract][Full Text] [Related]
25. Plasminogen-dependent and -independent proteolytic activity of murine endothelioma cells with targeted inactivation of fibrinolytic genes.
Lijnen HR; Wagner EF; Collen D
Thromb Haemost; 1997 Feb; 77(2):362-7. PubMed ID: 9157597
[TBL] [Abstract][Full Text] [Related]
26. Age dependence of blood fibrinolytic components and the effects of low-dose oral contraceptives on coagulation and fibrinolysis in teenagers.
Siegbahn A; Ruusuvaara L
Thromb Haemost; 1988 Dec; 60(3):361-4. PubMed ID: 3149043
[TBL] [Abstract][Full Text] [Related]
27. Rat pulmonary cyclooxygenase-2 expression in response to endotoxin challenge: differential regulation in the various types of cells in the lung.
Ermert L; Ermert M; Merkle M; Goppelt-Struebe M; Duncker HR; Grimminger F; Seeger W
Am J Pathol; 2000 Apr; 156(4):1275-87. PubMed ID: 10751353
[TBL] [Abstract][Full Text] [Related]
28. Differential effects of anti-cytokine treatment on bronchoalveolar hemostasis in endotoxemic chimpanzees.
Levi M; van Der POLL T; ten CATE H; Kuipers B; Biemond BJ; Jansen HM; ten CATE JW
Am J Respir Crit Care Med; 1998 Jul; 158(1):92-8. PubMed ID: 9655712
[TBL] [Abstract][Full Text] [Related]
29. Genetics of coagulation factors in acute lung injury.
Russell JA
Crit Care Med; 2003 Apr; 31(4 Suppl):S243-7. PubMed ID: 12682447
[TBL] [Abstract][Full Text] [Related]
30. Expression of fibrinolytic and coagulation factors in cocultured human endothelial and smooth muscle cells.
Helenius G; Heydarkhan-Hagvall S; Siegbahn A; Risberg B
Tissue Eng; 2004; 10(3-4):353-60. PubMed ID: 15165452
[TBL] [Abstract][Full Text] [Related]
31. Activation of coagulation and inhibition of fibrinolysis in the human lung on bronchial instillation of lipoteichoic acid and lipopolysaccharide.
Hoogerwerf JJ; de Vos AF; Levi M; Bresser P; van der Zee JS; Draing C; von Aulock S; van der Poll T
Crit Care Med; 2009 Feb; 37(2):619-25. PubMed ID: 19114879
[TBL] [Abstract][Full Text] [Related]
32. Changes in the fibrinolytic components of cultured human umbilical vein endothelial cells induced by endotoxin, tumor necrosis factor-alpha and interleukin-1alpha.
Orbe J; Chordá C; Montes R; Páramo JA
Haematologica; 1999 Apr; 84(4):306-11. PubMed ID: 10190943
[TBL] [Abstract][Full Text] [Related]
33. Pulmonary coagulation and fibrinolysis abnormalities that favor fibrin deposition in the lungs of mouse antibody-mediated transfusion-related acute lung injury.
Yu Y; Jiang P; Sun P; Su N; Lin F
Mol Med Rep; 2021 Aug; 24(2):. PubMed ID: 34165170
[TBL] [Abstract][Full Text] [Related]
34. Defibrotide reduces procoagulant activity and increases fibrinolytic properties of endothelial cells.
Falanga A; Vignoli A; Marchetti M; Barbui T
Leukemia; 2003 Aug; 17(8):1636-42. PubMed ID: 12886253
[TBL] [Abstract][Full Text] [Related]
35. Tissue fibrin deposition during acute lung injury in rabbits and its relationship to local expression of procoagulant and fibrinolytic activities.
Sitrin RG; Brubaker PG; Fantone JC
Am Rev Respir Dis; 1987 Apr; 135(4):930-6. PubMed ID: 3565941
[TBL] [Abstract][Full Text] [Related]
36. Chemical coupling of a monoclonal antisurfactant protein-B antibody to human urokinase for targeting surfactant-incorporating alveolar fibrin.
Ruppert C; Schmidt R; Grimminger F; Suzuki Y; Seeger W; Lehr CM; Günther A
Bioconjug Chem; 2002; 13(4):804-11. PubMed ID: 12121136
[TBL] [Abstract][Full Text] [Related]
37. Transcriptional regulation of tissue- and urokinase-type plasminogen activator genes by thrombin in human fetal lung fibroblasts.
Hayakawa Y; Tazawa S; Ishikawa T; Niiya K; Sakuragawa N
Thromb Haemost; 1995 Aug; 74(2):704-10. PubMed ID: 8585010
[TBL] [Abstract][Full Text] [Related]
38. Pathways of fibrin turnover of human pleural mesothelial cells in vitro.
Idell S; Zwieb C; Kumar A; Koenig KB; Johnson AR
Am J Respir Cell Mol Biol; 1992 Oct; 7(4):414-26. PubMed ID: 1389210
[TBL] [Abstract][Full Text] [Related]
39. Colistin dampens fibrinolysis and endothelial activation during endotoxaemia. A randomised, double blind trial.
Schoergenhofer C; Matzneller P; Mußbacher M; Schmid JA; Jilma-Stohlawetz P; Zeitlinger M; Jilma B
Thromb Haemost; 2017 Aug; 117(9):1714-1721. PubMed ID: 28796276
[TBL] [Abstract][Full Text] [Related]
40. Tissue factor-dependent coagulation activation and impaired fibrinolysis in situ in gastric cancer.
Wojtukiewicz MZ; Sierko E; Zacharski LR; Zimnoch L; Kudryk B; Kisiel W
Semin Thromb Hemost; 2003 Jun; 29(3):291-300. PubMed ID: 12888933
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
